The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer
Not Applicable
Not yet recruiting
- Conditions
- Gastric Cancer
- Registration Number
- NCT06977386
- Lead Sponsor
- Yunnan Cancer Hospital
- Brief Summary
Spectral CT was used to prospectively collect medical images and clinical data related to gastric cancer, evaluate the effect of image quality in the diagnosis of gastric cancer, and evaluate the application value in the accurate staging of gastric cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- (a)Patients with pathologically confirmed gastric cancer;
- (b) aged ≥ 18 years old;
- (c) have not received chemoradiotherapy or surgery.
Exclusion Criteria
- (a)Combined with other primary tumors;
- (b) The image quality does not meet the diagnostic criteria;
- (c)Those who cannot tolerate CT examination.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Pathological TNM staging 1 day Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Yunnan Cancer Hospital
🇨🇳Kunming City, Yunnan, China